The United States Food and Drug Administration (FDA) is investigating the popular heartburn medication Zantac (ranitidine). Individuals who took Zantac (by prescription or over-the-counter) and were diagnosed with bladder cancer, colorectal cancer, kidney cancer, pancreatic cancer, or stomach cancer (among other forms of cancer) should consider filing a Zantac lawsuit.
FDA ISSUES ZANTAC UPDATE: The FDA has announced that drug manufacturers are to immediately withdraw all Zantac and generic over-the-counter Zantac medications from the market. In the scope of its ongoing investigation, the agency determined that N-Nitrosodimethylamine (NDMA) in some ranitidine medications “increases over time and when stored at higher than room temperatures and may result in consumer exposure to unacceptable levels…” The U.S. Environmental Protection Agency (EPA), the World Health Organization (WHO), and the FDA classify NDMA as a substance that can cause cancer.
The law firm of Baum, Hedlund, Aristei & Goldman represents people in lawsuits against the manufacturers of Zantac. The Zantac cancer lawsuits allege that the popular heartburn drug leads to the formation of a potent cancer-causing chemical, NDMA, at levels over 3,000 times greater than the FDA’s legally allowable daily limit.
CA Man Says Zantac Medication Caused His Cancer – He has this to say to the drug makers: “Did you say, ‘We’re going to make a billion dollars and some people are going to die and that’s okay? We’ll make enough money that it won’t matter?’” https://t.co/zOEfyG52j1
Our Zantac videos are a helpful resource for information about the litigation. Our attorneys answer several of the most commonly asked questions about Zantac lawsuits. The videos can be watched in sequence, or you may click on the top left of the video window to select which video you would like to view.